Tg Therapeutics (TGTX) Change in Inventory (2023 - 2026)

Tg Therapeutics' Change in Inventory history runs 4 years deep, the most recent figure standing at $13.3 million for Q1 2026.

• In Q1 2026, Change in Inventory fell 71.33% year-over-year to $13.3 million; the TTM figure through Mar 2026 stood at $422000.0 (down 99.45% YoY), while the FY2025 annual figure was $33.5 million, down 49.96% from the prior year.
• Change in Inventory was $13.3 million for Q1 2026 at Tg Therapeutics, up from -$563000.0 in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $46.3 million in Q1 2025 to a low of -$8.7 million in Q3 2025.
• Historically, Change in Inventory has averaged $11.6 million across 4 years, with a median of $2.6 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Change in Inventory surged 350.78% in 2024, then plunged 442.32% in 2025.
• A 4-year view of Change in Inventory shows it stood at $5.5 million in 2023, then soared by 350.78% to $24.8 million in 2024, then plunged by 102.27% to -$563000.0 in 2025, then soared by 2457.9% to $13.3 million in 2026.
• The last three Change in Inventory figures came in at $13.3 million (Q1 2026), -$563000.0 (Q4 2025), and -$8.7 million (Q3 2025), per Business Quant data.